Archive | Cancer in the News

FDA grants fast track designation to ImmunoPulse IL-12 for melanoma

The FDA granted fast track designation to ImmunoPulse IL-12 for the treatment of metastatic melanoma that progressed during therapy with pembrolizumab or nivolumab.

Read the full story

Posted in Melanoma In The News, FDA

Melanoma Journal Articles for February 2017

Risk of cumulative toxicity after complete melanoma response with pembrolizumab.

Read the full story

Posted in Journal Articles

Melanoma Journal Articles for January 2017

An SVM Framework for Malignant Melanoma Detection Based on Optimized HOG Features.

Read the full story

Posted in Journal Articles

Melanoma Journal Articles for December 2016

Variants in autophagy-related genes and clinical characteristics in melanoma: a population-based study…

Read the full story

Posted in Journal Articles

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories